Gold and silver suffered the biggest sell-off in years, in a whipsawing reversal of a scorching rally that’s lifted prices to ...

Meta and the State of New York made separate announcements, each representing the largest potential nuclear capacity ...

See Q4 2025 revenue growth, premiumization trend, margins and FCF outlook, plus 2026 delivery impacts and Basic ...

So, in part owing to less attention paid to the trillion-dollar league (27.6% allocation vs. IVV's 38.3%), AVUS has an ...

EBITDA growth, dividend hikes and strong FCF as gas compression demand boosts margins—see valuation, risks & upside.

HIO trades at a 6.23% discount to NAV yet remains expensive relative to its 10-year historical range and recent performance.

The S&P 500 hit another all-time high but showed signs of fatigue, with momentum waning and technical cracks emerging. Learn ...

Supercomputing has shifted into the mainstream, with recent AI advancements and adoption making the use of massive amounts of ...

Reliability risks are spreading across much of the US bulk power system driven by soaring peak demand forecasts and lagging ...

A theoretical S&P 500 median company is overvalued by 13.3% versus 11-year historical averages, with quality scores near baseline. Learn more about EQWL here.

ResMed dominates the global sleep apnea device market, boasting a 50–60% share and a high-margin razor-razor-blade business model. See why RMD is a Strong Sell.

Realty Income's debt-to-EBITDA ratio is currently around 5.4x. For an A-rated REIT, that's acceptable—not concerning, but not ...